North America:

  • Tesla faces challenges with its robotaxi service, including legal actions, NHTSA scrutiny, and safety concerns, despite launching in Austin, Texas.
  • Google may be designated with 'strategic market status' by the UK's CMA to increase regulatory control over its search services.
  • Amazon plans to invest $54 billion in the UK by 2027, focusing on e-commerce and AI expansion.
  • AstraZeneca received US FDA approval for its cancer drug Datroway for non-small cell lung cancer.
  • Omnicom and Interpublic merger approved by the US FTC under a consent order to address anti-competitive concerns.
  • Amgen is expanding development plans for its weight-loss drug MariTide after promising mid-stage trial results.
  • Northern Trust rejected a merger offer from Bank of New York Mellon.
  • Goldman Sachs CEO calls for a review of European regulations and appoints Aek Shyam as head of M&A in its Global Real Estate Group.
  • Boeing is under investigation by the US safety board for its involvement in a 737 MAX 9 emergency.
  • Novo Nordisk terminated its partnership with Hims & Hers over concerns of illegal compounding and deceptive marketing, while expanding its market presence with Wegovy in India and Ozempic label update in Europe.

Europe:

  • Banca Monte dei Paschi di Siena received ECB approval for its proposed acquisition of Mediobanca, pending formal approval.
  • Eni fined 32 million euros by the Italian antitrust authority for market abuse and acquired Acea Energia for approximately 589 million euros.
  • Volvo Construction Equipment sold a 70% stake in SDLG for $837 million and acquired Swecon's operations for 7 billion Swedish kronor.
  • Continental AG revised its 2025 profitability targets downward and plans to sell its Contitech business unit.

Rest of the world:

  • Adani Group denied allegations of FCPA violations, while Adani Enterprises' Mumbai Airport secured $750 million in financing.
  • Virgin Australia shares surged by 8.3% during their trading debut following the airline's IPO.
  • Starbucks faces conflicting reports about a potential sale of its operations in China.
  • Nissan shareholders criticized the company's management amid an intensifying crisis.